<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="162974">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01711996</url>
  </required_header>
  <id_info>
    <org_study_id>4-2012-0421</org_study_id>
    <nct_id>NCT01711996</nct_id>
  </id_info>
  <brief_title>The Correlation Between Renal Injury and Biomarkers in Pediatric Ureteropelvic Junction Obstruction Patients</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <authority>Korea: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Urinary Neutrophil gelatinase associated lipocalin (NGAL) has been recently reported to be
      related with the degree of hydronephrosis in pediatric ureteropelvic junction obstruction
      (UPJO) patients. We are trying to analyze whether it is related with the grade of renal
      injury in UPJO patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">August 2013</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>The level of urinary NGAL and the degree of renal injury</measure>
    <time_frame>6 month  after operation</time_frame>
    <safety_issue>No</safety_issue>
    <description>Analysis of correlation between the level of urinary NGAL and the degree of renal injury</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Ureteropelvic Junction Obstruction</condition>
  <arm_group>
    <arm_group_label>UPJO</arm_group_label>
    <description>0-3 year old hydronephrosis patients without ureter dilatation who undergo pyeloplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydronephrosis</arm_group_label>
    <description>0-3 year old hydronephrosis patients without ureter dilatation who does not meet the indication of pyeloplasty</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal</arm_group_label>
    <description>0-3 year old children without hydronephrosis</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Group 1: 20 patients with UPJO undergo pyeloplasty Group 2: 20 patients with
        hydronephrosis who does not meet the indication of pyeloplasty Group 3: 20 normal control
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        &lt;Group 1&gt;

          1. 0-3 year old patients with SFU grade 2 or more hydronephrosis without ureteral
             dilatation

          2. needs pyeloplasty due to differential renal function (DRF)&lt;40%, decreased DRF by more
             than 5%, development of urinary tract infection, development of urinary stone, and
             development of pain related with UPJO &lt;Group 2&gt;

        1. 0-3 year old patients with SFU grade 3 or 4 hydronephrosis without ureteral dilatation
        2. doesn't meet the above criteria for the indication of pyeloplasty &lt;Group 3&gt;

        1. 0-3 year old children without any abnormality of urinary tract

        Exclusion Criteria:

        &lt;Group 1&gt;

          1. patients with contralateral disease affecting DRF

          2. history of previous urinary tract surgery

          3. follow up loss before diuretic renogram performed at 6-12 months from operation
             &lt;Group 2, 3&gt;

        1. patients with contralateral disease affecting DRF 2. history of previous urinary tract
        surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>3 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Han Sang Won, MD</last_name>
    <phone>82-2-2228-2316,</phone>
    <email>swhan@yuhs.ac</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Urology, Urological Science Institute, Yonsei University, Colleage of Medicine</name>
      <address>
        <city>Seoul</city>
        <zip>120-752</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sang Won MD, MD</last_name>
      <phone>82-2-2228-2316</phone>
      <email>swhan@yuhs.ac</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <lastchanged_date>October 22, 2012</lastchanged_date>
  <firstreceived_date>October 17, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>hydronephrosis</keyword>
  <keyword>biopsy</keyword>
  <keyword>biomarker</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
